small molecule glp-1 receptor agonist Docking pose and chemical structure of the C-1 Small molecule GLP-1 agonists. |
Description
Meta-analyses of randomized controlled trials have found that GLP-1 receptor agonists reduced liver fat content by approximately 2.53% absolute reduction in PDFF compared to placebo or active comparators
Characterized by insulin resistance, gradual progressive loss of insulin secretion by -cells, and being heavily driven by being overweight or obese [98], T2DM leads to hyperglycemia, excessive urine production, increased risk of cardiovascular disease, and changes in energy metabolism [106]
Recuperato da: Wium-Andersen IK, Wium-Andersen MK, Fink-Jensen A, Rungby J, Jrgensen MB, Osler M
With DeleteMe, you can take control and help keep your personal data private
